Infliximab and Arthritis Treatment Programs

Infliximab has been part of arthritis treatment programs for a significant period of time. The treatment is sold under the brand name Remicade. They are part of the anti tumor necrosis factor class. In the event they will reduce inflammation and some of the other symptoms that are associated with the condition. You can only be given this medication where the arthritis is active. Under the rules this is a prescription drug that you will get after the approval of a clinician. The administration is through a drip that targets a specified vein. There are over two hours required to complete the infusion of Infliximab. The patient is monitored for two hours to ensure that they are not reacting negatively to the treatment. The patient and their families have to watch out for the side effects which can be devastating if they are not stopped in their tracks.

Responsible usage of Infliximab

It is imperative that you do not take on the medication without the approval of your family doctor. They are in an ideal position to make decisions about your welfare. They will also be able to determine whether any form of treatment is effective in the long run. After the first bout of treatment the doctors will have a cooling off period of about two weeks before they start once again. The infusion will continue on an eight week cycle. The need for a biological therapy card is based on the experiences of people that are responsible for treating patients in an emergency. If you see no response within twelve weeks then it is time for the clinician to look at alternatives. Arthritis is a chronic condition and therefore you should not expect instant results even if you are taking the medication diligently.

Some of the side effects that have been associated with Infliximab included a blocked or runny nose, dizziness, headaches, rashes and stomach pain. It is imperative that these symptoms are addressed as a priority within the context of keeping the patient healthy. In cases where the patient has a serious case of red blood cell deficiency then the intake of Infliximab may make matters worse. That is why a blood test might be required prior to the full prescription. Patients that develop soreness, a cold or paleness should discuss these symptoms with the doctor. It might be that Infliximab is not the ideal treatment at that point in time. There is no point in continuing with the treatment if it is going to make matters worse in the long run. It is far better to look for alternative solutions. Shingles might indicate that the immune system is compromised and the patient needs to look at alternatives.

It is possible to have an allergic reaction to Infliximab. If that is the case then the treatment must be stopped with immediate effect. The signs of an allergic reaction include breathing difficulties and low blood pressure. These are the decisions that need to be taken in order to ensure that the patient’s life is not placed in danger.